A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer

Autor: LEVINE, M.N. *, GU, C., LIEBMAN, H.A., ESCALANTE, C.P., SOLYMOSS, S., DEITCHMAN, D., RAMIREZ, L., JULIAN, J.
Zdroj: In Journal of Thrombosis and Haemostasis May 2012 10(5):807-814
Databáze: ScienceDirect
Externí odkaz: